Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



5 Pharmaceutical Stocks With Major Exposure to Emerging Markets

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

The world economy is on two different tracks.

On one track, the developed world is experiencing economic contraction and stagnating growth. Countries throughout Europe have stumbled into recession due to austerity measures. Japan persists on its decade-long path of lackluster growth. And the U.S. economy, while rebounding, continues to underperform its potential, recording growth of only 2.2% in the first quarter of 2012.

On the other track, the developing world is recording robust economic growth. Spurred by the twin tailwinds of easy external financing and a dramatic uptick in commodity prices, output from Latin America grew by 6.5% in 2010 and 4.5% last year. And the emerging markets in Asia continue their dramatic upward ascent, led by China and India, which are expected to record growth rates this year of 8.2% and 6.9%, respectively.

The corporate poster child of this two-track system is Yum! Brands, the U.S.-based proprietor of Pizza Hut, Taco Bell, and KFC. In 2011, the company's same-store sales declined by 1% in the United States but grew by 19% in China. More than 70% of its operating profit is now generated abroad. And its shares have outperformed those of its principal competitor --  McDonald's, which derives a full 40% of its revenues from Europe -- by a staggering 28 percentage points over the last five years.

With this in mind, I've created two different series of articles. The first identified stocks with significant exposure to Europe's ailing economy. I looked at popular stocks, Dow stocks, tech stocks, consumer-goods stocks, and pharmaceutical stocks. The second, and current, series uncovers stocks with major exposure to the fast growth of Asia and other emerging markets. So far, I've looked at popular stocks, Dow stocks, tech stocks, and consumer-goods stocks. Below is my list of pharmaceutical stocks.


Asia and Emerging Market Exposure (percent of net sales)

Market Cap (billions)

Add to My Watchlist

Abbott Laboratories (NYSE: ABT  )




Johnson & Johnson (NYSE: JNJ  )




Merck (NYSE: MRK  )




Pfizer (NYSE: PFE  )




Bristol-Myers  Squibb (NYSE: BMY  )




All geographic sales figures are the author's estimates of exposure to Asia and the emerging markets based on data in the companies' quarterly and annual filings. Market cap data is from Yahoo! Finance. Some, like Merck and Abbott Laboratories, also include sales from "other" countries.

While none of these companies has the same level of exposure to Asia and the emerging markets as, say, most tech companies do, it's clear the region is a prominent part of their growth strategies.

Just this week, Abbott Laboratories said it's looking to have a fully integrated business model to grow its nutrition business in India. According to a senior executive: "India is a growth area for us. We have research now. To be fully integrated [there], we will have everything from research to manufacturing to sales."

Last year, Johnson & Johnson announced the opening of an "innovation center" in China where it will design products specifically for Asia's emerging markets.

Merck has committed to investing $1.5 billion in Asia-based research and development, including the construction of a new R&D headquarters in Beijing.

Both Pfizer and Bristol-Myers Squibb are making similar inroads in the growing region.

Foolish bottom line
While diversification is no cure-all, it is one component of successful investing in modern times. For a handful of stock ideas to get you started down this path, check out our free report about three American companies set to dominate the globe. To get your free copy while it's still available, click here now.

Fool contributor John Maxfield does not have a financial position in any of the companies mentioned above. The Motley Fool owns shares of Johnson & Johnson and Abbott Laboratories. Motley Fool newsletter services have recommended buying shares of Johnson & Johnson, Pfizer, Yum! Brands, and McDonald's. Motley Fool newsletter services have recommended creating a diagonal call position in Johnson & Johnson. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.

Read/Post Comments (0) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1903588, ~/Articles/ArticleHandler.aspx, 10/21/2016 2:49:52 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,145.51 -16.84 -0.09%
S&P 500 2,141.02 -0.32 -0.01%
NASD 5,252.23 10.40 0.20%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/21/2016 2:34 PM
ABT $40.55 Down -0.19 -0.47%
Abbott Laboratorie… CAPS Rating: *****
BMY $50.00 Down -0.36 -0.71%
Bristol-Myers Squi… CAPS Rating: ****
JNJ $113.58 Down -1.30 -1.13%
Johnson and Johnso… CAPS Rating: ****
MRK $61.22 Down -0.70 -1.13%
Merck and Co. CAPS Rating: ****
PFE $32.25 Down -0.29 -0.89%
Pfizer CAPS Rating: ****